Day 28 landmark analysis of grade III-IV aGVHD according to day 28 ST2 level. Patients who engrafted and were without grade II-IV aGVHD at day 28 were included in the analysis (n = 106). Elevated day 28 ST2 was associated with a significantly increased risk of subsequent severe aGVHD.